Treace Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Treace Medical Concepts
TMCI Stock  USD 2.54  0.04  1.60%   
Treace Medical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Treace Medical's valuation are provided below:
Gross Profit
174.8 M
Profit Margin
(0.23)
Market Capitalization
164.4 M
Enterprise Value Revenue
0.8103
Revenue
218.9 M
We have found one hundred twenty available fundamental trend indicators for Treace Medical Concepts, which can be analyzed and compared to other ratios and to its competition. Traders should compare all of Treace Medical Concepts current fundamentals against the fundamentals between 2010 and 2026 to make sure the company is sustainable this year. The Treace Medical's current Enterprise Value is estimated to increase to about 1.1 B, while Market Cap is projected to decrease to under 504.9 M.

Treace Medical Total Revenue

133.74 Million

Check Treace Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Treace Medical's main balance sheet or income statement drivers, such as Interest Income of 5.9 M, Depreciation And Amortization of 10.2 M or Interest Expense of 4.4 M, as well as many indicators such as Price To Sales Ratio of 2.41, Dividend Yield of 0.0 or PTB Ratio of 4.47. Treace financial statements analysis is a perfect complement when working with Treace Medical Valuation or Volatility modules.
  
Build AI portfolio with Treace Stock
Check out the analysis of Treace Medical Correlation against competitors.

Treace Medical Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets154.1 M249.7 M88.9 M
Slightly volatile
Short and Long Term Debt Total52.8 M80.1 M34.9 M
Slightly volatile
Other Current Liabilities19.3 M27.6 M12.3 M
Slightly volatile
Total Current Liabilities27 M40.2 M16.5 M
Slightly volatile
Total Stockholder Equity74.9 M129.8 M37.7 M
Slightly volatile
Property Plant And Equipment Net41.5 M39.6 M11 M
Slightly volatile
Accounts Payable7 M12.1 M3.9 M
Slightly volatile
Cash9.7 M10.2 M18.2 M
Pretty Stable
Non Current Assets Total67.2 M64 M16.5 M
Slightly volatile
Long Term Debt43.4 M61.3 M30.3 M
Slightly volatile
Cash And Short Term Investments76.3 M87 M40.5 M
Slightly volatile
Net Receivables27.8 M46.9 M18.8 M
Slightly volatile
Common Stock Total Equity42.9 K63.2 K36.7 K
Slightly volatile
Common Stock Shares Outstanding61.4 M71.4 M54.6 M
Slightly volatile
Liabilities And Stockholders Equity154.1 M249.7 M88.9 M
Slightly volatile
Non Current Liabilities Total52.2 M79.7 M34.7 M
Slightly volatile
Inventory47.4 M45.1 M15 M
Slightly volatile
Other Current Assets3.9 M6.5 M2.1 M
Slightly volatile
Other Stockholder Equity365.5 M348.1 M100.7 M
Slightly volatile
Total Liabilities79.2 M119.8 M51.2 M
Slightly volatile
Net Invested Capital115.7 M191.1 M62.8 M
Slightly volatile
Property Plant And Equipment Gross60 M57.2 M14.6 M
Slightly volatile
Total Current Assets128.5 M185.6 M74.8 M
Slightly volatile
Capital Stock53 K55.8 K5.2 M
Slightly volatile
Net Working Capital101.4 M145.4 M58.3 M
Slightly volatile
Common Stock51.3 K71.3 K38.5 K
Slightly volatile
Property Plant Equipment18.5 M17.6 M5.7 M
Slightly volatile
Current Deferred Revenue6 M6.8 M7.4 M
Slightly volatile
Short and Long Term Debt1.4 M1.6 M1.8 M
Slightly volatile
Short Term Debt353.1 K371.7 K1.3 M
Slightly volatile
Long Term Debt Total45.1 M60.6 M36.3 M
Slightly volatile
Capital Surpluse154.1 M167 M139.8 M
Slightly volatile
Deferred Long Term Liabilities138.4 K155.7 K169.9 K
Slightly volatile
Other Assets116.8 K131.4 K143.4 K
Slightly volatile
Intangible Assets6.8 M7.3 M8.7 M
Slightly volatile

Treace Medical Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Interest Income5.9 M5.6 M1.4 M
Slightly volatile
Depreciation And Amortization10.2 M9.7 M2.7 M
Slightly volatile
Interest Expense4.4 M6 M2.5 M
Slightly volatile
Selling General Administrative67.3 M64.1 M19.8 M
Slightly volatile
Selling And Marketing Expenses94.6 M169.8 M59.6 M
Slightly volatile
Total Revenue133.7 M240.8 M85.8 M
Slightly volatile
Gross Profit107.9 M193.5 M69.2 M
Slightly volatile
Other Operating Expenses163.3 M304.8 M102.7 M
Slightly volatile
Research Development13 M23.7 M9 M
Slightly volatile
Cost Of Revenue25.8 M47.3 M16.6 M
Slightly volatile
Total Operating Expenses137.5 M257.5 M86 M
Slightly volatile
Reconciled Depreciation10.2 M9.7 M2.6 M
Slightly volatile
Income Tax Expense3.8 M6 M2.3 M
Slightly volatile
Preferred Stock And Other Adjustments156.8 K176.4 K192.5 K
Slightly volatile

Treace Medical Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation37 M35.2 M8.3 M
Slightly volatile
Begin Period Cash Flow14.2 M14.9 M12.4 M
Slightly volatile
Depreciation10.2 M9.7 M2.7 M
Slightly volatile
Other Non Cash Items6 M5.7 M1.8 M
Slightly volatile
Capital Expenditures7.9 M13.3 M4.4 M
Slightly volatile
Change To Operating Activities11.3 M10.8 M5.5 M
Slightly volatile
Total Cash From Financing Activities174.8 K184 K26.3 M
Pretty Stable
End Period Cash Flow9.7 M10.2 M18.2 M
Pretty Stable
Change To Netincome10.5 M10 M3.7 M
Slightly volatile
Dividends Paid6.3 M7.1 M7.8 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio2.412.5422.655
Slightly volatile
PTB Ratio4.474.71345
Slightly volatile
Days Sales Outstanding88.1781.8189.325
Slightly volatile
Book Value Per Share0.931.640.5941
Slightly volatile
Stock Based Compensation To Revenue0.140.130.0485
Slightly volatile
Capex To Depreciation2.251.242.004
Slightly volatile
PB Ratio4.474.71345
Slightly volatile
EV To Sales2.722.8622.8182
Slightly volatile
Inventory Turnover1.511.21.3704
Pretty Stable
Days Of Inventory On Hand218314268
Pretty Stable
Payables Turnover5.124.496.547
Slightly volatile
Sales General And Administrative To Revenue0.160.240.1525
Slightly volatile
Research And Ddevelopement To Revenue0.110.09830.1172
Slightly volatile
Capex To Revenue0.03990.04980.0391
Slightly volatile
Cash Per Share0.971.10.6742
Slightly volatile
Days Payables Outstanding70.6284.1163.8351
Slightly volatile
Income Quality1.090.771.4114
Slightly volatile
Intangibles To Total Assets0.07320.08660.0865
Pretty Stable
Current Ratio3.794.164.2037
Slightly volatile
Tangible Book Value Per Share0.841.330.5297
Slightly volatile
Receivables Turnover3.74.624.1253
Slightly volatile
Shareholders Equity Per Share0.931.640.5941
Slightly volatile
Debt To Equity0.670.716.1581
Pretty Stable
Capex Per Share0.0960.170.0716
Slightly volatile
Revenue Per Share1.693.031.4293
Slightly volatile
Interest Debt Per Share0.731.090.6364
Slightly volatile
Debt To Assets0.480.370.547
Slightly volatile
Operating Cycle282378355
Pretty Stable
Price Book Value Ratio4.474.71345
Slightly volatile
Days Of Payables Outstanding70.6284.1163.8351
Slightly volatile
Company Equity Multiplier2.12.219.4166
Pretty Stable
Long Term Debt To Capitalization0.570.370.6944
Slightly volatile
Total Debt To Capitalization0.610.440.712
Slightly volatile
Debt Equity Ratio0.670.716.1581
Pretty Stable
Quick Ratio3.23.153.4477
Pretty Stable
Cash Ratio0.360.371.5243
Pretty Stable
Cash Conversion Cycle211294291
Slightly volatile
Days Of Inventory Outstanding218314268
Pretty Stable
Days Of Sales Outstanding88.1781.8189.325
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.021.181.1942
Slightly volatile
Price To Book Ratio4.474.71345
Slightly volatile
Fixed Asset Turnover6.657.028.0892
Slightly volatile
Debt Ratio0.480.370.547
Slightly volatile
Price Sales Ratio2.412.5422.655
Slightly volatile
Asset Turnover1.091.111.1827
Slightly volatile
Gross Profit Margin0.650.720.7917
Slightly volatile
Price Fair Value4.474.71345
Slightly volatile

Treace Medical Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap504.9 M531.4 M1.1 B
Slightly volatile
Enterprise Value1.1 B598.5 M1.2 B
Slightly volatile

Treace Fundamental Market Drivers

Treace Upcoming Events

27th of February 2024
Upcoming Quarterly Report
View
13th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
27th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Treace Medical Financial Statements

Investors use fundamental indicators, such as Treace Medical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Treace Medical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue6.8 M6 M
Total Revenue240.8 M133.7 M
Cost Of Revenue47.3 M25.8 M
Stock Based Compensation To Revenue 0.13  0.14 
Sales General And Administrative To Revenue 0.24  0.16 
Research And Ddevelopement To Revenue 0.10  0.11 
Capex To Revenue 0.05  0.04 
Revenue Per Share 3.03  1.69 
Ebit Per Revenue(0.31)(0.32)

Currently Active Assets on Macroaxis

HITIHigh Tide
HITIHigh Tide
BACBank of America
SSentinelOne
GMGeneral Motors
When determining whether Treace Medical Concepts offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Treace Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Treace Medical Concepts Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Treace Medical Concepts Stock:
How To Invest In Treace
Details
Is Treace Stock a good investment?
Details
What is Treace Medical's Net Worth?
Details
Largest Health Care Equipment & Supplies Companies
View
Largest Health Care Equipment & Services Companies
View
Check out the analysis of Treace Medical Correlation against competitors.
You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Treace Medical. If investors know Treace will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Treace Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.80)
Revenue Per Share
3.48
Quarterly Revenue Growth
0.114
Return On Assets
(0.15)
Return On Equity
(0.52)
The market value of Treace Medical Concepts is measured differently than its book value, which is the value of Treace that is recorded on the company's balance sheet. Investors also form their own opinion of Treace Medical's value that differs from its market value or its book value, called intrinsic value, which is Treace Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Treace Medical's market value can be influenced by many factors that don't directly affect Treace Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Treace Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Treace Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Treace Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY